CETP and autosomal recessive limb-girdle muscular dystrophy type 2B: Future studies are needed to determine whether increasing HDL-C is of therapeutic values in LGMD2B patients and lowering HDL-C through CETP activity can further refine MD modeling in settings of high CHOL levels.